Advent Pharma Past Earnings Performance
Past criteria checks 1/6
Advent Pharma's earnings have been declining at an average annual rate of -12.5%, while the Pharmaceuticals industry saw earnings growing at 10.3% annually. Revenues have been declining at an average rate of 1.1% per year. Advent Pharma's return on equity is 6.3%, and it has net margins of 16.2%.
Key information
-12.5%
Earnings growth rate
-12.5%
EPS growth rate
| Pharmaceuticals Industry Growth | 11.0% |
| Revenue growth rate | -1.1% |
| Return on equity | 6.3% |
| Net Margin | 16.2% |
| Last Earnings Update | 31 Mar 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Advent Pharma makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 24 | 569 | 92 | 87 | 0 |
| 31 Dec 23 | 564 | 92 | 92 | 0 |
| 30 Sep 23 | 558 | 93 | 90 | 0 |
| 30 Jun 23 | 558 | 99 | 88 | 0 |
| 31 Mar 23 | 552 | 98 | 87 | 0 |
| 31 Dec 22 | 548 | 99 | 88 | 0 |
| 30 Sep 22 | 542 | 99 | 87 | 0 |
| 30 Jun 22 | 530 | 98 | 87 | 0 |
| 31 Mar 22 | 526 | 110 | 92 | 0 |
| 31 Dec 21 | 507 | 104 | 88 | 0 |
| 30 Sep 21 | 504 | 116 | 83 | 0 |
| 30 Jun 21 | 504 | 114 | 79 | 0 |
| 31 Mar 21 | 445 | 94 | 61 | 0 |
| 31 Dec 20 | 464 | 94 | 62 | 0 |
| 30 Sep 20 | 492 | 98 | 67 | 0 |
| 30 Jun 20 | 534 | 117 | 71 | 0 |
| 31 Mar 20 | 589 | 140 | 76 | 0 |
| 31 Dec 19 | 604 | 165 | 70 | 0 |
| 30 Sep 19 | 619 | 169 | 71 | 0 |
| 30 Jun 19 | 602 | 158 | 71 | 0 |
| 31 Mar 19 | 606 | 172 | 80 | 0 |
| 31 Dec 18 | 541 | 144 | 81 | 0 |
| 30 Sep 18 | 456 | 112 | 77 | 0 |
| 30 Jun 18 | 396 | 87 | 76 | 0 |
| 31 Mar 18 | 357 | 64 | 60 | 0 |
| 30 Sep 17 | 318 | 57 | 54 | 0 |
| 30 Jun 17 | 285 | 49 | 50 | 0 |
| 30 Jun 16 | 228 | 28 | 47 | 0 |
Quality Earnings: ADVENT has high quality earnings.
Growing Profit Margin: ADVENT's current net profit margins (16.2%) are lower than last year (17.8%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: ADVENT's earnings have declined by 12.5% per year over the past 5 years.
Accelerating Growth: ADVENT's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: ADVENT had negative earnings growth (-6.2%) over the past year, making it difficult to compare to the Pharmaceuticals industry average (0.6%).
Return on Equity
High ROE: ADVENT's Return on Equity (6.3%) is considered low.